tiprankstipranks
Trending News
More News >
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market

Kazia Therapeutics (KZIA) Income Statement

Compare
298 Followers

Kazia Therapeutics Income Statement

Last quarter (Q4 2024), Kazia Therapeutics's total revenue was AU$2.48M, an increase of Infinity% from the same quarter last year. In Q4, Kazia Therapeutics's net income was AU$-17.95M. See Kazia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 2.31MAU$ 555.00AU$ 25.00AU$ 15.18MAU$ 1.06K
Gross Profit
AU$ 2.31MAU$ 555.00AU$ 25.00AU$ 15.18MAU$ 1.06K
Operating Expenses
AU$ 2.31MAU$ 24.12MAU$ 24.88MAU$ 24.13MAU$ 13.16M
Depreciation and Amortization
AU$ 1.87MAU$ 1.87MAU$ 1.87MAU$ 1.26MAU$ 1.08M
EBITDA
AU$ -26.77MAU$ -22.28MAU$ -23.51MAU$ -5.11MAU$ -11.11M
Operating Income
AU$ 0.00AU$ -24.12MAU$ -26.70MAU$ -6.38MAU$ -12.53M
Other Income/Expenses
AU$ -27.05MAU$ 3.39MAU$ 0.00AU$ -2.53MAU$ -569.58K
Pretax Income
AU$ -27.05MAU$ -20.74MAU$ -25.02MAU$ -8.91MAU$ -12.77M
Net Income
AU$ -26.78MAU$ -20.47MAU$ -24.65MAU$ -8.42MAU$ -12.47M
Per Share Metrics
Basic EPS
AU$ -55.85AU$ -55.55AU$ -93.05AU$ -35.80AU$ -81.75
Diluted EPS
AU$ -55.85AU$ -55.55AU$ -93.05AU$ -35.80AU$ -81.75
Weighted Average Shares Outstanding
479.60K 368.60K 265.00K 235.40K 152.46K
Weighted Average Shares Outstanding (Diluted)
479.60K 368.60K 265.00K 235.40K 152.46K
Currency in AUD

Kazia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis